MANNATECH INC

MANNATECH INCMTEXEarnings & Financial Report

Nasdaq · Consumer Staples · Medicinal Chemicals & Botanical Products

Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates.

Revenue

$27.7M

Gross Profit

$21.4M

Operating Profit

$-1.1M

Net Profit

$-624.0K

Gross Margin

77.1%

Operating Margin

-4.1%

Net Margin

-2.2%

YoY Growth

-14.9%

EPS

$-0.33

MANNATECH INC Q2 FY2024 Financial Summary

MANNATECH INC reported revenue of $27.7M (down 14.9% YoY) for Q2 FY2024, with a net profit of $-624.0K (up 43.5% YoY) (-2.2% margin). Cost of goods sold was $6.4M, operating expenses totaled $22.5M.

Key Financial Metrics

Total Revenue$27.7M
Net Profit$-624.0K
Gross Margin77.1%
Operating Margin-4.1%
Report PeriodQ2 FY2024

Revenue Breakdown

MANNATECH INC Q2 FY2024 revenue of $27.7M breaks down across 2 segments, led by Consolidated Product Sales at $26.3M (94.8% of total).

SegmentRevenue% of Total
Consolidated Product Sales$26.3M94.8%
Consolidated Pack Sales$1.0M3.6%

MANNATECH INC Revenue by Segment — Quarterly Trend

MANNATECH INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Consolidated Product Sales and Consolidated Pack Sales) has evolved quarter over quarter.

SegmentQ3 FY2025Q1 FY2025Q4 FY2024Q3 FY2024
Consolidated Product Sales$25.5M$28.0M$30.1M
Consolidated Pack Sales$700.0K$1.3M

MANNATECH INC Annual Revenue by Year

MANNATECH INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $117.9M).

YearAnnual Revenue
2024$117.9M
2023$132.0M
2022$137.2M

MANNATECH INC Quarterly Revenue & Net Profit History

MANNATECH INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q3 FY2025$29.2M-8.1%$1.9M6.6%
Q1 FY2025$26.6M-9.6%$-1.5M-5.8%
Q4 FY2024$29.0M-11.3%$2.3M7.8%
Q3 FY2024$31.7M-2.5%$-328.0K-1.0%
Q2 FY2024$27.7M-14.9%$-624.0K-2.2%
Q1 FY2024$29.4M-13.8%$1.2M4.0%
Q4 FY2023$32.7M-4.8%$-1.8M-5.4%
Q3 FY2023$32.6M-8.3%$18.0K0.1%

Income Statement

Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q3 2025
Revenue$32.6M$32.7M$29.4M$27.7M$31.7M$29.0M$26.6M$29.2M
YoY Growth-8.3%-4.8%-13.8%-14.9%-2.5%-11.3%-9.6%-8.1%

Balance Sheet

Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q3 2025
Assets$42.2M$41.2M$41.1M$39.9M$40.6M$36.1M$36.7M$33.9M
Liabilities$31.5M$30.7M$30.6M$31.7M$30.6M$27.4M$29.1M$27.0M
Equity$10.7M$10.5M$10.4M$8.2M$10.0M$8.6M$7.6M$7.0M

Cash Flow

Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q3 2025
Operating CF$287000$-1.3M$1.9M$-2.7M$3.3M$-219000$-1.4M$-1.3M